Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Anti-infectivesPRM 5931
Dosage formHard-gelatin capsules
Oral

Bacillus Mesentericus TO-A 2 million, Cefixime 200 mg, Clostridium Butyricum TO-A 4 million, Lactic Acid Bacillus 100 million, Streptococcus Faecalis TO-110 60 million

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Cephalosporin antibiotic + Probiotic / prebiotic
Manufacturing stream
Beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5932
Dosage formHard-gelatin capsules
Oral

Bacillus Mesentericus TO-A 2 million, Cefpodoxime 200 mg, Clostridium Butyricum TO-A 4 million, Lactic Acid Bacillus 100 million, Streptococcus Faecalis TO-110 60 million

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Cephalosporin antibiotic + Probiotic / prebiotic
Manufacturing stream
Beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5971
Dosage formOral suspension
Oral

Bromhexine 2 mg, Cephalexin 125 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Cephalosporin antibiotic + Mucolytic
Manufacturing stream
Beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5933
Dosage formHard-gelatin capsules
Oral

Bromhexine 4 mg, Cephalexin 250 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Cephalosporin antibiotic + Mucolytic
Manufacturing stream
Beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5972
Dosage formOral suspension
Oral

Bromhexine 4 mg, Cephalexin 250 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Cephalosporin antibiotic + Mucolytic
Manufacturing stream
Beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5934
Dosage formHard-gelatin capsules
Oral

Bromhexine 8 mg, Cephalexin 500 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Cephalosporin antibiotic + Mucolytic
Manufacturing stream
Beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5935
Dosage formHard-gelatin capsules
Oral

Carbocisteine 150 mg, Cephalexin 250 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Cephalosporin antibiotic + Mucolytic
Manufacturing stream
Beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5973
Dosage formOral suspension
Oral

Carbocisteine 150 mg, Cephalexin 250 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Cephalosporin antibiotic + Mucolytic
Manufacturing stream
Beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5936
Dosage formHard-gelatin capsules
Oral

Carbocisteine 150 mg, Cephalexin 500 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Cephalosporin antibiotic + Mucolytic
Manufacturing stream
Beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5853
Dosage formTablets
Oral

Cefaclor 375 mg (MR)

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
Class III
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5854
Dosage formTablets
Oral

Cefaclor 750 mg (MR)

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
Class III
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5987
Dosage formOral drops
Oral

Cefaclor Monohydrate 100 mg / ml

Route
Oral
Formulation type
Oral liquid drops
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5974
Dosage formOral suspension
Oral

Cefaclor Monohydrate 125 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5975
Dosage formOral suspension
Oral

Cefaclor Monohydrate 187 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5937
Dosage formHard-gelatin capsules
Oral

Cefaclor Monohydrate 250 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
Class III
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5976
Dosage formOral suspension
Oral

Cefaclor Monohydrate 250 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5938
Dosage formHard-gelatin capsules
Oral

Cefaclor Monohydrate 500 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
Class III
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5939
Dosage formHard-gelatin capsules
Oral

Cefadroxil 1 gm

Same composition also available as

Tablets

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5855
Dosage formTablets
Oral

Cefadroxil 1 gm

Same composition also available as

Hard-gelatin capsules

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5977
Dosage formOral suspension
Oral

Cefadroxil 125 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5957
Dosage formSyrup
Oral

Cefadroxil 125 mg, Clavulanic Acid 31.25 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Beta-lactamase inhibitor + Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5856
Dosage formTablets
Oral

Cefadroxil 250 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5857
Dosage formTablets
Oral

Cefadroxil 250 mg, Clavulanic Acid 62.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Beta-lactamase inhibitor + Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
Class III (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Anti-infectivesPRM 5958
Dosage formSyrup
Oral

Cefadroxil 250 mg, Clavulanic Acid 62.5 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Beta-lactamase inhibitor + Cephalosporin antibiotic
Manufacturing stream
Beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product